China Meheco Links Up With Pfizer to Market Covid Pill
China Meheco Corp. (600056.SH) secured a partnership with Pfizer Inc. to bring the American pharmaceutical giant’s new Covid-19 pill to the Chinese mainland, the state-owned drug maker said Wednesday.
Meheco said it signed a 2022 supply contract with Pfizer authorizing the Chinese company to commercialize Paxlovid in China. The agreement details delivery, payments, quality guarantee and assessment, contract termination and dispute resolution involving the partnership.
- MOST POPULAR